期刊
BRITISH JOURNAL OF CANCER
卷 108, 期 5, 页码 1178-1181出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/bjc.2013.73
关键词
head and neck cancer; ibuprofen; aspirin; cohort study
类别
资金
- Division of Cancer Prevention, National Cancer Institute
- NIH, DHHS
- ESRC [ES/G007438/1] Funding Source: UKRI
- Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish
Background: Evidence for non-steroidal anti-inflammatory drugs (NSAIDs) preventing head and neck cancer (HNC) is inconclusive; however, there is some suggestion that aspirin may exert a protective effect. Methods: Using data from the United States National Cancer Institute Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, we examined the association between aspirin and ibuprofen use and HNC. Results: Regular aspirin use was associated with a significant 22% reduction in HNC risk. No association was observed with regular ibuprofen use. Conclusion: Aspirin may have potential as a chemopreventive agent for HNC, but further investigation is warranted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据